» Articles » PMID: 17035457

How Viral Infections Cause Exacerbation of Airway Diseases

Overview
Journal Chest
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2006 Oct 13
PMID 17035457
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Exacerbations of asthma and COPD are major causes of morbidity, mortality, and health-care costs. Over the last decade, studies using new molecular diagnostic techniques have established that respiratory viruses are a major cause of exacerbations of both asthma and COPD. The most prevalent viruses detected during exacerbations are the rhinoviruses. Despite the burden of disease associated with exacerbations, little is known about the mechanisms of virus-induced exacerbations of airway diseases. Exacerbations are associated with increased airway inflammation in patients with both asthma and COPD, but many questions remain unanswered regarding the key inflammatory cells and mediators involved. Identifying the key inflammatory mediators involved in exacerbations holds the promise of developing diagnostic and prognostic markers of exacerbation. In addition, such studies can identify new therapeutic targets for the development of novel drugs for the prevention and treatment of exacerbations.

Citing Articles

Insights from respiratory virus co-infections.

Georgakopoulou V World J Virol. 2024; 13(4):98600.

PMID: 39722753 PMC: 11551690. DOI: 10.5501/wjv.v13.i4.98600.


Nebulised interferon beta-1a (SNG001) in the treatment of viral exacerbations of COPD.

Monk P, Brookes J, Tear V, Batten T, Newall C, Mankowski M Respir Res. 2024; 25(1):228.

PMID: 38811970 PMC: 11138078. DOI: 10.1186/s12931-024-02854-7.


BRD4 is involved in viral exacerbation of chronic obstructive pulmonary disease.

Duan Y, Zhou S, Wang J Respir Res. 2023; 24(1):37.

PMID: 36721187 PMC: 9887738. DOI: 10.1186/s12931-023-02348-y.


Phenotypic comparison of human alveolar macrophages before and after in vivo rhinovirus 16 challenge.

de Groot L, Brinkman P, Sabogal Pineros Y, Priller J, Hamann J, Bottcher C Eur J Immunol. 2021; 51(11):2691-2693.

PMID: 34492126 PMC: 9292529. DOI: 10.1002/eji.202149222.


[Influenza and cardiorespiratory events: a clinical-epidemiological review with a multidisciplinary point of view].

Carro Hevia A, Sanz Hernandez F, Alvarez Aldean J, Garcia Cenoz M, Jimeno Sanz I, Redondo Marguello E Rev Esp Quimioter. 2021; 34(6):556-568.

PMID: 34256558 PMC: 8638758. DOI: 10.37201/req/065.2021.


References
1.
Fraenkel D, Bardin P, SANDERSON G, Lampe F, Johnston S, Holgate S . Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med. 1995; 151(3 Pt 1):879-86. DOI: 10.1164/ajrccm/151.3_Pt_1.879. View

2.
Kling S, Donninger H, Williams Z, Vermeulen J, Weinberg E, Latiff K . Persistence of rhinovirus RNA after asthma exacerbation in children. Clin Exp Allergy. 2005; 35(5):672-8. DOI: 10.1111/j.1365-2222.2005.02244.x. View

3.
Roland M, Bhowmik A, Sapsford R, Seemungal T, Jeffries D, Warner T . Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease. Thorax. 2000; 56(1):30-5. PMC: 1745915. DOI: 10.1136/thorax.56.1.30. View

4.
Proud D, Sanders S, Wiehler S . Human rhinovirus infection induces airway epithelial cell production of human beta-defensin 2 both in vitro and in vivo. J Immunol. 2004; 172(7):4637-45. DOI: 10.4049/jimmunol.172.7.4637. View

5.
Hewson C, Jardine A, Edwards M, Laza-Stanca V, Johnston S . Toll-like receptor 3 is induced by and mediates antiviral activity against rhinovirus infection of human bronchial epithelial cells. J Virol. 2005; 79(19):12273-9. PMC: 1211516. DOI: 10.1128/JVI.79.19.12273-12279.2005. View